US FDA finds "significant violations" at India's Strides plant

The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XTiTqf
via IFTTT

0 comments:

Post a Comment